{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:34:18Z","timestamp":1794015258763,"version":"4.8.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,4,26]]},"DOI":"10.1001\/jama.2022.4983","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T15:40:40Z","timestamp":1650987640000},"page":"1577","source":"Crossref","is-referenced-by-count":345,"title":["Aspirin Use to Prevent Cardiovascular Disease"],"prefix":"10.1001","volume":"327","author":[{"name":"US Preventive Services Task Force","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina W.","family":"Davidson","sequence":"additional","affiliation":[{"name":"Feinstein Institutes for Medical Research at Northwell Health, Manhasset, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Barry","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol M.","family":"Mangione","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cabana","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chelmow","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tumaini Rucker","family":"Coker","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa M.","family":"Davis","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina E.","family":"Donahue","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Roberto","family":"Ja\u00e9n","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H.","family":"Krist","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University, Richmond"},{"name":"Fairfax Family Practice Residency, Fairfax, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Kubik","sequence":"additional","affiliation":[{"name":"George Mason University, Fairfax, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbenga","family":"Ogedegbe","sequence":"additional","affiliation":[{"name":"New York University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Pbert","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School, Worcester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Ruiz","sequence":"additional","affiliation":[{"name":"University of Arizona, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stevermer","sequence":"additional","affiliation":[{"name":"University of Missouri, Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wen","family":"Tseng","sequence":"additional","affiliation":[{"name":"University of Hawaii, Honolulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Wong","sequence":"additional","affiliation":[{"name":"Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"jus220007r1","first-page":"1","article-title":"Deaths: leading causes for 2017.","volume":"68","author":"Heron","year":"2019","journal-title":"Natl Vital Stat Rep"},{"issue":"8","key":"jus220007r2","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics\u20142021 update: a report from the American Heart Association.","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"25, pt B","key":"jus220007r4","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"jus220007r5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.7326\/M14-1281","article-title":"An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.","volume":"162","author":"DeFilippis","year":"2015","journal-title":"Ann Intern Med"},{"issue":"11","key":"jus220007r6","doi-asserted-by":"publisher","first-page":"786","DOI":"10.7326\/M16-1739","article-title":"Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update.","volume":"165","author":"Cook","year":"2016","journal-title":"Ann Intern Med"},{"issue":"18","key":"jus220007r7","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.jacc.2016.02.055","article-title":"Accuracy of the atherosclerotic cardiovascular risk equation in a large contemporary, multiethnic population.","volume":"67","author":"Rana","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"jus220007r8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.7326\/M16-2543","article-title":"Accuracy of cardiovascular risk prediction varies by neighborhood socioeconomic position: a retrospective cohort study.","volume":"167","author":"Dalton","year":"2017","journal-title":"Ann Intern Med"},{"issue":"3","key":"jus220007r9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005676","article-title":"Performance of the atherosclerotic cardiovascular disease pooled cohort risk equations by social deprivation status.","volume":"6","author":"Colantonio","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"9678","key":"jus220007r10","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"issue":"21","key":"jus220007r11","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1001\/jama.2012.5034","article-title":"Association of aspirin use with major bleeding in patients with and without diabetes.","volume":"307","author":"De Berardis","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"jus220007r12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.7326\/M18-2808","article-title":"Predicting bleeding risk to guide aspirin use for the primary prevention of cardiovascular disease: a cohort study.","volume":"170","author":"Selak","year":"2019","journal-title":"Ann Intern Med"},{"issue":"2","key":"jus220007r13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00535-013-0817-y","article-title":"Primary non-variceal upper gastrointestinal bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication in two large Dutch cohorts.","volume":"49","author":"de Groot","year":"2014","journal-title":"J Gastroenterol"},{"issue":"19","key":"jus220007r15","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1001\/jama.2016.15450","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement.","volume":"316","author":"US Preventive Services Task Force","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"jus220007r16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jama.2020.25019","article-title":"Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement.","volume":"325","author":"US Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"issue":"20","key":"jus220007r17","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1001\/jama.2020.21749","article-title":"Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US Preventive Services Task Force recommendation statement.","volume":"324","author":"US Preventive Services Task Force","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"jus220007r18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jama.2017.7171","article-title":"Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without cardiovascular risk factors: US Preventive Services Task Force recommendation statement.","volume":"318","author":"US Preventive Services Task Force","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"jus220007r19","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jama.2018.13022","article-title":"Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement.","volume":"320","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"issue":"16","key":"jus220007r20","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1001\/jama.2021.4987","article-title":"Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement.","volume":"325","author":"US Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"jus220007r21","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jama.2021.12531","article-title":"Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement.","volume":"326","author":"US Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"issue":"19","key":"jus220007r22","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","article-title":"Screening for colorectal cancer: US Preventive Services Task Force recommendation statement.","volume":"325","author":"US Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"jus220007r23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive Services Task Force recommendation statement.","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann Intern Med"},{"issue":"16","key":"jus220007r24","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly.","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"jus220007r25","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2022.3337","article-title":"Aspirin use to prevent cardiovascular disease and colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force.","author":"Guirguis-Blake","year":"2022","journal-title":"JAMA"},{"key":"jus220007r27","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2022.3385","article-title":"Aspirin use to prevent cardiovascular disease and colorectal cancer: updated modeling study for the US Preventive Services Task Force.","author":"Dehmer","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"jus220007r28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians\u2019 Health Study.","volume":"321","author":"Steering Committee of the Physicians\u2019 Health Study Research Group","year":"1989","journal-title":"N Engl J Med"},{"issue":"2","key":"jus220007r29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7326\/0003-4819-159-2-201307160-00002","article-title":"Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial.","volume":"159","author":"Cook","year":"2013","journal-title":"Ann Intern Med"},{"issue":"9098","key":"jus220007r30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","article-title":"Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk: the Medical Research Council\u2019s General Practice Research Framework.","volume":"351","year":"1998","journal-title":"Lancet"},{"issue":"9754","key":"jus220007r31","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"issue":"9","key":"jus220007r32","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association.","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"jus220007r33","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1152\/physrev.00004.2008","article-title":"Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn\u2019t the stomach digest itself?","volume":"88","author":"Wallace","year":"2008","journal-title":"Physiol Rev"},{"issue":"11","key":"jus220007r34","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/phar.2012.32.issue-11","article-title":"Aspirin for primary prevention of cardiovascular disease events.","volume":"32","author":"Nemerovski","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"11","key":"jus220007r35","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"jus220007r14","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2022.3337","volume-title":"Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: An Evidence Update for the US Preventive Services Task Force. Evidence Synthesis No. 211","author":"Guirguis-Blake","year":"2022"},{"key":"jus220007r26","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2022.3385","volume-title":"Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: An Updated Decision Analysis for the US Preventive Services Task Force","author":"Dehmer","year":"2022"},{"key":"jus220007r3","unstructured":"US Preventive Services Task Force. US Preventive Services Task Force Procedure Manual. Published 2021. Accessed March 8, 2022. https:\/\/uspreventiveservicestaskforce.org\/uspstf\/about-uspstf\/methods-and-processes\/procedure-manual"},{"key":"jus220007r36","unstructured":"American Academy of Family Physicians. Clinical preventive service recommendations: aspirin use to prevent CVD and colorectal cancer. Accessed March 8, 2022. https:\/\/www.aafp.org\/family-physician\/patient-care\/clinical-recommendations\/all-clinical-recommendations\/aspirin-use-prevention.html"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2791399\/jama_davidson_2022_us_220007_1650466044.25397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T15:18:28Z","timestamp":1675437508000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2791399"}},"subtitle":["US Preventive Services Task Force Recommendation Statement"],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":36,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022,4,26]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.4983","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,26]]}}}